Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation

Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation

Rationale: Psilocybin is a serotonergic psychedelic that has gained prominent attention recently as a potential therapeutic for neuropsychiatric disorders including Major Depressive Disorder. Pre-clinical and initial studies in humans suggest that serotonin 2A receptor agonists, including serotonerg...

Full description

Bibliographic Details
Main Authors: Daniel Rødbro Burmester, Martin Korsbak Madsen, Attila Szabo, Sagar Sanjay Aripaka, Dea Siggaard Stenbæk, Vibe G. Frokjaer, Betina Elfving, Jens D. Mikkelsen, Gitte Moos Knudsen, Patrick MacDonald Fisher
Format: Article
Language:English
Published: Elsevier 2023-02-01
Series:Comprehensive Psychoneuroendocrinology
Subjects:
Psilocybin
Inflammation
Neuroinflammation
Biomarkers
Psychedelics
Immune system
Online Access:http://www.sciencedirect.com/science/article/pii/S2666497622000546

Internet

http://www.sciencedirect.com/science/article/pii/S2666497622000546

Similar Items